The mutations in TP53, CDKN2A, and FAT1 genes reported in prior works are found to be tightly associated with HNSCC development (Coombes et al., 2003; Eriksen et al., 2005). This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.